Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Some treatments can improve skin's defense against damage, but overuse may cause other skin problems.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Lhx2 is essential for effective Sonic Hedgehog signaling in early retinal development.

A new mutation in the hHb1 keratin gene is linked to the hair disorder monilethrix.

Mutations in the hHb6 gene cause the hair disorder monilethrix.

Pachyonychia congenita is linked to a keratin gene on chromosome 17.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

A specific gene mutation causes Olmsted syndrome.

Provenge extends prostate cancer survival by about 4 months.

CRABP2 helps increase the growth of cells important for hair growth by activating a specific growth pathway.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Pmg-1 and Pmg-2 are new genes important for skin and mammary gland development.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

17β-estradiol can reduce inflammation in the skin.

Adding a specific gene to skin cells can help treat skin disorders like psoriasis.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

BMP-2 activates the Dlx3 gene in mouse skin cells, important for hair and skin development.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Dermatologists should consider congenital syndromes like TRPS in young adults with early hair loss.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Sox13 is a new marker for early hair follicle development and differentiation.